Conceptualizing and Measuring Abatement from the Opioid Epidemic: A Case Study from Pennsylvania

Danielle Rhubart; Qiushi Chen; Glenn Sterner; Robert Newton; Bethany Shaw; Dennis Scanlon

doi:10.1111/1468-0009.12589

Conceptualizing and Measuring Abatement from the Opioid Epidemic: A Case Study from Pennsylvania

Danielle Rhubart, Qiushi Chen, Glenn Sterner, Robert Newton, Bethany Shaw, Dennis Scanlon

Research output: Contribution to journal › Article › peer-review

Abstract

Policy Points In 2021, four major pharmaceutical manufacturers and distributors reached a proposed settlement agreement with 46 state Attorneys General of $26 billion to address their liabilities in fueling the US opioid epidemic. It raises important questions about abatement conceptualization and measurement for allocating settlement funds among substate entities. We outline the political economy tensions undergirding the settlement and allocation, introduce an abatement conceptual framework, describe how an abatement formula was developed for Pennsylvania to allocate settlement funds, and summarize considerations for future settlement allocation efforts. Documenting the challenges and experiences of this task is essential to inform future efforts.

Original language	English (US)
Pages (from-to)	991-1005
Number of pages	15
Journal	Milbank Quarterly
Volume	100
Issue number	4
DOIs	https://doi.org/10.1111/1468-0009.12589
State	Published - Dec 2022

All Science Journal Classification (ASJC) codes

Health Policy
Public Health, Environmental and Occupational Health

Access to Document

10.1111/1468-0009.12589

Cite this

@article{9a8f92ca05b84030825fee8c45d1dfa2,

title = "Conceptualizing and Measuring Abatement from the Opioid Epidemic: A Case Study from Pennsylvania",

abstract = "Policy Points In 2021, four major pharmaceutical manufacturers and distributors reached a proposed settlement agreement with 46 state Attorneys General of $26 billion to address their liabilities in fueling the US opioid epidemic. It raises important questions about abatement conceptualization and measurement for allocating settlement funds among substate entities. We outline the political economy tensions undergirding the settlement and allocation, introduce an abatement conceptual framework, describe how an abatement formula was developed for Pennsylvania to allocate settlement funds, and summarize considerations for future settlement allocation efforts. Documenting the challenges and experiences of this task is essential to inform future efforts.",

author = "Danielle Rhubart and Qiushi Chen and Glenn Sterner and Robert Newton and Bethany Shaw and Dennis Scanlon",

note = "Publisher Copyright: {\textcopyright} 2022 Milbank Memorial Fund.",

year = "2022",

month = dec,

doi = "10.1111/1468-0009.12589",

language = "English (US)",

volume = "100",

pages = "991--1005",

journal = "Milbank Quarterly",

issn = "0887-378X",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - Conceptualizing and Measuring Abatement from the Opioid Epidemic

T2 - A Case Study from Pennsylvania

AU - Rhubart, Danielle

AU - Chen, Qiushi

AU - Sterner, Glenn

AU - Newton, Robert

AU - Shaw, Bethany

AU - Scanlon, Dennis

PY - 2022/12

Y1 - 2022/12

N2 - Policy Points In 2021, four major pharmaceutical manufacturers and distributors reached a proposed settlement agreement with 46 state Attorneys General of $26 billion to address their liabilities in fueling the US opioid epidemic. It raises important questions about abatement conceptualization and measurement for allocating settlement funds among substate entities. We outline the political economy tensions undergirding the settlement and allocation, introduce an abatement conceptual framework, describe how an abatement formula was developed for Pennsylvania to allocate settlement funds, and summarize considerations for future settlement allocation efforts. Documenting the challenges and experiences of this task is essential to inform future efforts.

AB - Policy Points In 2021, four major pharmaceutical manufacturers and distributors reached a proposed settlement agreement with 46 state Attorneys General of $26 billion to address their liabilities in fueling the US opioid epidemic. It raises important questions about abatement conceptualization and measurement for allocating settlement funds among substate entities. We outline the political economy tensions undergirding the settlement and allocation, introduce an abatement conceptual framework, describe how an abatement formula was developed for Pennsylvania to allocate settlement funds, and summarize considerations for future settlement allocation efforts. Documenting the challenges and experiences of this task is essential to inform future efforts.

UR - http://www.scopus.com/inward/record.url?scp=85143422547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85143422547&partnerID=8YFLogxK

U2 - 10.1111/1468-0009.12589

DO - 10.1111/1468-0009.12589

M3 - Article

C2 - 36441694

AN - SCOPUS:85143422547

SN - 0887-378X

VL - 100

SP - 991

EP - 1005

JO - Milbank Quarterly

JF - Milbank Quarterly

IS - 4

ER -

Conceptualizing and Measuring Abatement from the Opioid Epidemic: A Case Study from Pennsylvania

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this